PBI-01220

N/A

Report date: 2023/03/05 18:10:23
NME

Base Information

Drug NamePBI-01220
Drug Alias NamePBI-01220
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action78 kDa glucose-regulated protein inhibitorsEnvelope glycoprotein inhibitors
Targets78 kDa glucose-regulated proteinEnvelope glycoprotein
Therapy Area/IndicationsVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPhoenix Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesPhoenix Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsVirus Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A